GRAIL, Inc. (BMV:GRAL)

Mexico flag Mexico · Delayed Price · Currency is MXN
767.08
0.00 (0.00%)
At close: Jun 3, 2025
Market Cap 26.72B
Revenue (ttm) 2.67B
Net Income (ttm) -39.13B
Shares Out n/a
EPS (ttm) -1,196.03
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 309
Average Volume 1,250
Open 767.08
Previous Close n/a
Day's Range 767.08 - 767.08
52-Week Range 246.28 - 827.00
Beta n/a
RSI n/a
Earnings Date May 13, 2025

About GRAIL

GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and DAC, a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients for whom there is a clinical suspicion of cancer. The company also provides development services, including support for ongoing clinical studies, pilot testing, research, and therapy development. In addition, it... [Read more]

Industry In Vitro and In Vivo Diagnostic Substances
Founded 2015
Employees 1,000
Stock Exchange Mexican Stock Exchange
Ticker Symbol GRAL
Full Company Profile

Financial Performance

In 2024, GRAIL's revenue was $125.60 million, an increase of 34.90% compared to the previous year's $93.11 million. Losses were -$2.03 billion, 38.3% more than in 2023.

Financial numbers in USD Financial Statements

News

There is no news available yet.